Year 2020, Volume 4 , Issue 6, Pages 501 - 504 2020-06-01

Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia?
C-reaktif protein - albümin oranı akut alt ekstremite iskemisinde amputasyon gelişiminin öngörücüsü olarak kullanılabilir mi?

Burak ERDOLU [1] , Mesut ENGİN [2]


Aim: Acute lower limb ischemia is a cardiovascular emergency that occurs due to embolic and thrombotic causes. Inflammatory biomarkers obtained from routine blood parameters have been used in the diagnosis and progression of many cardiovascular diseases. In this study, we aimed to reveal the predictive value of C reactive protein to albumin ratio (CAR) in predicting limb loss, which is a significantly morbid result of thromboembolectomy.
Methods: Patients who were admitted to our clinic with acute lower extremity ischemia between March 15, 2015-March 15, 2018 and who underwent thromboembolectomy were included in this retrospective cohort study. The patients in which no extremity amputation was performed after the surgery were included in Group 1 and those in which amputation was performed in the early post-operative period (in-hospital) were included in Group 2. Multivariate logistic regression analysis was utilized to predict parameters supporting amputation in patients with lower extremity thromboembolism.
Results: There were 207 patients in Group 1 and 32 in Group 2. Amputation was performed above the knee in 5 patients (15.6%), below the knee in 23 patients (71.8%) and below the ankle in 4 patients (12.5%) in Group 2. The mean age of patients in Groups 1 and 2 were 58.7 (9.8) years and 68.3 (10.3) years, respectively (P<0.001). In the regression analysis, advanced age (OR: 1.045, CI 95%: 1.004-2.144, P=0.011), CAR (OR: 1.679, CI 95%: 1.224-3.794, P=0.005) and hospital admission time (OR: 1.054, CI 95%: 1.010-1.458, P=0.022) were determined as independent predictors for amputation.
Conclusion: The CAR value obtained from routine blood parameters obtained before the procedure may be a good predictor of amputation risk.

Amaç: Akut alt ekstremite iskemisi embolik ve trombotik nedenlerden dolayı ortaya çıkan kardiyovasküler acil bir durumdur. Rutin kan parametrelerinden elde edilen inflamatuar biyobelirteçler birçok kardiyovasküler hastalığın tanısında ve progresyonunda kullanılmıştır. Bu çalışmada, tromboembolektominin önemli bir morbid sonucu olan ekstremite kaybının öngörülmesinde C reaktif proteinin albümin oranının (CAR) prediktif değerini ortaya koymayı amaçladık.
Yöntemler: Kliniğimize akut alt ekstremite iskemi durumu olan 15 Mart 2015-15 Mart 2018 tarihleri arasında başvuran ve tromboembolektomi uygulanan hastalar bu retrospektif kohort çalışmasına dahil edildi. Ameliyat sonrası ekstremite amputasyonu yapılmayan hastalar Grup 1, ameliyat sonrası erken dönemde (hasteneiçi) amputasyon yapılan hastalar Grup 2 olarak kaydedildi.
Bulgular: Hastaların 207'si Grup 1'e, 32'si Grup 2'ye dahil edildi. 5 hastada (%15,6) diz üstünde, 23 hastada (%71,8) diz altında ve 4 hastada (%12,5) ayak bileği altında amputasyon yapıldı. Grup 1'deki hastaların ortalama yaşı 58,7 (9,8) iken, Grup 2'deki hastalar 68,3 (10,3) idi (P<0,001). Alt ekstremite tromboembolizmi olan hastalarda amputasyonu destekleyen parametreleri tahmin etmek için çok değişkenli lojistik regresyon analizi kullanıldı. Bu değerlendirmede, ileri yaş (OR: 1,045, CI% 95: 1,004-2,144, P=0,011), CAR (OR: 1,679, CI %95: 1,224-3,794, P=0,005) ve hastaneye başvuru zamanı (OR: 1,054, CI %95: 1,010-1,458, P=0,022) amputasyonu göstermek için bağımsız prediktörler olarak belirlendi.
Sonuç: Sonuç olarak, işlemden önce alınan rutin kan parametrelerinden elde edilen CAR değeri amputasyon riskinin iyi bir prediktörü olabilir.

  • 1. Vemulapalli S, Patel MR, Jones WS. Limb ischemia: cardiovascular diagnosis and management from head to toe. Curr Cardiol Rep. 2015;17:611.
  • 2. Aldağ M, Öztekin A, Bademci MŞ, Kocaaslan C, Denli Yalvaç EŞ, Aydın E. Surgical results of acute thromboembolic limb ischemia in octogenarians. Damar Cer Derg. 2018;27(3):111-6.
  • 3. Akgül E, Engin M, Özyazıcıoğlu AF. Effects of mean platelet volume and platelet counts on peripheral biodegradable stent restenosis. J Surg Med. 2019;3(9):663-5.
  • 4. Kaya BB, Özbilgin N. Effect of cardiac rehabilitation on mortality related inflammatory markers. J Surg Med. 2019;3(8):588-92.
  • 5. Moon AR, Choi DH, Jahng SY, Kim BB, Seo HJ, Kim SH, et al. High-sensitivity C-reactive protein and mean platelet volume as predictive values after percutaneous coronary intervention for longterm clinical outcomes: a comparable and additive study. Blood Coagul Fibrinolysis. 2016; 271:70–6.
  • 6. Melander O, Newton-Cheh C, Almgren P, Hedblad B, Berglund G, Engström G, et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA. 2009;302:49–57.
  • 7. Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018 Jun;52:8-12.
  • 8. Duman H, Cinier G, Bakırcı EM, Duman H, Simsek Z, Hamur H, et al. Relationship between C-reactive protein to albumin ratio and thrombus burden in patients with acute coronary syndrome. Clin Appl Thromb Hemost. 2019;25:1076029618824418.
  • 9. Cınar T, Çagdas M, Rencuzogulları I, Karakoyun S, Karabag Y, Yesin M, et al. Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction. Scand Cardiovasc J. 2019;53:83–90.
  • 10. Ueberrueck T, Marusch F, Schmidt H, Gastinger I. Risk factors and management of arterial emboli of the upper and lower extremities. J Cardiovasc Surg. 2007;48:181–6.
  • 11. Davi G and Patrono C. Platelet activation and atherothrombosis. N Engl J Med. 2007;357:2482–94.
  • 12. Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology. 2007;58:513–22.
  • 13. Khera A, De Lemos JA, Peshock RM, Lo HS, Staneg HG, Murphy SA, et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation. 2006;113(1):38-43.
  • 14. Pant S, Deshmukh A, Gurumurthy GS, Pothineni NV, Watts TE, Romeo F, et al. Inflammation and atherosclerosis—revisited. J Cardiovasc Pharmacol Ther. 2013;19(2):170-8.
  • 15. Bisoendial RJ, Boekholdt SM, Vergeer M, Stroes ESG, Kastelein JJP. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J. 2010;31(17):2087-91.
  • 16. Murat SN, Kurtul A, Yarlioglues M. Impact of serum albumin levels on contrast-induced acute kidney injury in patients with acute coronary syndromes treated with percutaneous coronary intervention. Angiology. 2015;66(8):732-37.
  • 17. Schalk BW, Visser M, Bremmer MA, Penninx BW, Bouter LM, Deeg DJ. Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam. Am J Epidemiol. 2006;164(10):969-77.
  • 18. Kurtul A, Murat SN, Yarlioglues M, Duran M, Ocek AH, Koseoglu C, et al. Usefulness of serum albumin concentration to predict high coronary SYNTAX score and in-hospital mortality in patients with acute coronary syndrome. Angiology. 2016;67:34-40.
  • 19. Joles JA, Willekes-Koolschijn N, Koomans HA. Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. Kidney Int. 1997;52:761-70.
  • 20. Mikhailidis D, Ganotakis E. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996;7:125-37.
  • 21. Karabag Y, Cagdas M, Rencuzogulları I, Karakoyun S, Artac I, Ilis D, et al. Usefulness of The C-Reactive Protein/Albumin Ratio for Predicting No-Reflow in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. Eur J Clin Invest. 2018;48(6):e12928.
  • 22. Cagdas M, Rencuzogulları I, Karakoyun S, Karabag Y, Yesin M, Artac I, et al. Assessment of Relationship Between C-Reactive Protein to Albumin Ratio and Coronary Artery Disease Severity in Patients With Acute Coronary Syndrome. Angiology. 2019;70(4):361‐8.
  • 23. Fairclough E, Cairns E, Hamilton J, Kelly C. Evaluation of a modified early warning system for acute medical admissions and comparison with C-reactive protein/albumin ratio as a predictor of patient outcome. Clin Med (Lond). 2009;9(1):30-3.
  • 24. Saskin H, Ozcan KS, Duzyol C, Baris O, Kocogulları UC. Are inflammatory parameters predictors of amputation in acute arterial occlusions? Vascular. 2017;25(2):170‐7.
  • 25. Kubat E, Erol G, Akyol FB, Karabacak K, Kadan M, Doğancı S, et al. Comparison of embolectomy outcomes for acute lower limb ischemia between patients aged ≥80 years and <80 years. Turk J Vasc Surg. 2020;29(2):84-9.
Primary Language en
Subjects Peripheral Vascular Disease
Journal Section Research article
Authors

Orcid: 0000-0002-4679-8682
Author: Burak ERDOLU
Institution: BURSA YÜKSEK İHTİSAS SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ
Country: Turkey


Orcid: 0000-0003-2418-5823
Author: Mesut ENGİN (Primary Author)
Institution: SBÜ Şanlıurfa Mehmet Akif İnan EAH
Country: Turkey


Dates

Publication Date : June 1, 2020

Bibtex @research article { josam753862, journal = {Journal of Surgery and Medicine}, issn = {}, eissn = {2602-2079}, address = {jsurgmed@gmail.com}, publisher = {Fatih BAŞAK}, year = {2020}, volume = {4}, pages = {501 - 504}, doi = {10.28982/josam.753862}, title = {Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia?}, key = {cite}, author = {Erdolu, Burak and Engi̇n, Mesut} }
APA Erdolu, B , Engi̇n, M . (2020). Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia? . Journal of Surgery and Medicine , 4 (6) , 501-504 . DOI: 10.28982/josam.753862
MLA Erdolu, B , Engi̇n, M . "Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia?" . Journal of Surgery and Medicine 4 (2020 ): 501-504 <http://jsurgmed.com/en/pub/issue/54767/753862>
Chicago Erdolu, B , Engi̇n, M . "Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia?". Journal of Surgery and Medicine 4 (2020 ): 501-504
RIS TY - JOUR T1 - Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia? AU - Burak Erdolu , Mesut Engi̇n Y1 - 2020 PY - 2020 N1 - doi: 10.28982/josam.753862 DO - 10.28982/josam.753862 T2 - Journal of Surgery and Medicine JF - Journal JO - JOR SP - 501 EP - 504 VL - 4 IS - 6 SN - -2602-2079 M3 - doi: 10.28982/josam.753862 UR - https://doi.org/10.28982/josam.753862 Y2 - 2020 ER -
EndNote %0 Journal of Surgery and Medicine Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia? %A Burak Erdolu , Mesut Engi̇n %T Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia? %D 2020 %J Journal of Surgery and Medicine %P -2602-2079 %V 4 %N 6 %R doi: 10.28982/josam.753862 %U 10.28982/josam.753862
ISNAD Erdolu, Burak , Engi̇n, Mesut . "Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia?". Journal of Surgery and Medicine 4 / 6 (June 2020): 501-504 . https://doi.org/10.28982/josam.753862
AMA Erdolu B , Engi̇n M . Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia?. J Surg Med. 2020; 4(6): 501-504.
Vancouver Erdolu B , Engi̇n M . Can C-reactive protein to albumin ratio be used as a predictor of amputation development in acute lower extremity ischemia?. Journal of Surgery and Medicine. 2020; 4(6): 501-504.